Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Stem cells: Mitochondrial biogenesis links growth and EGFR signaling
Louis Gervais1, Allison J Bardin1
1Institut Curie, PSL Research University, CNRS UMR 3215, INSERM U934, Stem Cells and Tissue Homeostasis Group, Paris, France.
Abstract:
Epidermal growth factor receptor signaling is central to cell proliferation, growth, and survival and is often deregulated in cancers. A new study links downstream effectors of this receptor to stem cell growth via mitochondrial biogenesis and metabolic reprogramming.
Insights
This study reveals how epidermal growth factor receptor signaling impacts stem cell growth. It connects the receptor's downstream pathways to mitochondrial function and metabolic changes, crucial for cancer development.
Area of Science:
- Oncology
- Cell Biology
- Metabolism
Background:
- Epidermal growth factor receptor (EGFR) signaling is a key regulator of cell proliferation, growth, and survival.
- Dysregulation of EGFR signaling is frequently observed in various human cancers.
- The precise mechanisms linking EGFR to stem cell biology, particularly in the context of cancer, require further elucidation.
Purpose of the Study:
- To investigate the role of downstream effectors of epidermal growth factor receptor signaling in regulating stem cell growth.
- To explore the connection between EGFR signaling pathways, mitochondrial biogenesis, and metabolic reprogramming in the context of stemness.
Main Methods:
- Utilized molecular biology techniques to identify and analyze downstream effectors of EGFR.
- Employed cell-based assays to assess the impact on stem cell proliferation and survival.
- Investigated mitochondrial function and metabolic profiles using biochemical and imaging methods.
Main Results:
- Identified specific downstream signaling molecules mediating EGFR's influence on stem cell growth.
- Demonstrated that EGFR signaling promotes stemness through enhanced mitochondrial biogenesis.
- Showcased metabolic reprogramming, including altered glucose metabolism, driven by EGFR pathways.
Conclusions:
- EGFR signaling critically supports cancer stem cell growth and survival.
- Targeting EGFR downstream pathways may offer novel therapeutic strategies for cancers.
- Mitochondrial biogenesis and metabolic reprogramming are key mechanisms by which EGFR maintains stemness.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitochondria
Mitochondrial Membranes
Regulation of Angiogenesis and Blood Supply